ICICI Securities Limited
ICICI Securities Ltd | Retail Equity Research Revenues declined 4.0% YoY to | 2287.1 crore (I-direct estimate: | 2607.7 crore) due to 14% YoY de-growth in the US to | 848.3 crore (I-direct estimate: | 1092.5 crore). Domestic formulations grew 6.2% YoY to | 786.2 crore (I-direct estimate: | 778.7 crore) EBITDA margins declined 134 bps to 22.9% (I-direct estimate: 23.9%) on account of higher employee cost. EBITDA declined 9.3% YoY to | 523.9 crore (I-direct estimate: | 622.3 crore)...
Zydus Lifesciences Ltd. is trading below its 30 day SMA of 1012.2
More from Zydus Lifesciences Ltd.
Recommended